EMA management board: highlights of June 2022 meeting

20 June 2022
ema-2022-european-union-2022-large

At its June 16, 2022, meeting in Amsterdam, the European Medicines Agency's (EMA) management board, among other items, heard an update about the implementation of the new  EU regulation that reinforces EMA’s role in crisis preparedness and management for medicinal products and medical devices.

The newly-established  Medicines Shortages Steering Group (MSSG) had its first meeting on May 11 and is now fully operational. It has been put in place to mitigate and respond to medicine supply issues caused by major events or public health emergencies. The Emergency Task Force (ETF), which was originally convened in March 2020 to specifically address the  COVID-19 pandemic, started operating under the new rules in mid-April. The board adopted the rules of procedure via written procedure of both entities in April.

Annual Activity Report 2021

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical